标题
PEGylated liposomes: immunological responses
作者
关键词
-
出版物
SCIENCE AND TECHNOLOGY OF ADVANCED MATERIALS
Volume 20, Issue 1, Pages 710-724
出版商
Informa UK Limited
发表日期
2019-06-26
DOI
10.1080/14686996.2019.1627174
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- A hydroxyl PEG version of PEGylated liposomes and its impact on anti-PEG IgM induction and on the accelerated clearance of PEGylated liposomes
- (2018) Taro Shimizu et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Antibody-modified liposomes for tumor-targeting delivery of timosaponin AIII
- (2018) Lu Lu et al. International Journal of Nanomedicine
- PEGylated TiO2 nanoparticles mediated inhibition of cell migration via integrin beta 1
- (2018) Qingqing Sun et al. SCIENCE AND TECHNOLOGY OF ADVANCED MATERIALS
- Progress and challenges towards targeted delivery of cancer therapeutics
- (2018) Daniel Rosenblum et al. Nature Communications
- Pre-existing anti-polyethylene glycol antibody reduces the therapeutic efficacy and pharmacokinetics of PEGylated liposomes
- (2018) Yuan-Chin Hsieh et al. Theranostics
- Functional biomimetic nanoparticles for drug delivery and theranostic applications in cancer treatment
- (2018) Lei Li et al. SCIENCE AND TECHNOLOGY OF ADVANCED MATERIALS
- Nanomedicinal products: a survey on specific toxicity and side effects
- (2017) Walter Brand et al. International Journal of Nanomedicine
- Ganglioside inserted into PEGylated liposome attenuates anti-PEG immunity
- (2017) Yu Mima et al. JOURNAL OF CONTROLLED RELEASE
- Complement activation turnover on surfaces of nanoparticles
- (2017) S.M. Moghimi et al. Nano Today
- ‘Borono-lectin’ based engineering as a versatile platform for biomedical applications
- (2017) Akira Matsumoto et al. SCIENCE AND TECHNOLOGY OF ADVANCED MATERIALS
- Factor H Family Proteins in Complement Evasion of Microorganisms
- (2017) Mihály Józsi Frontiers in Immunology
- Accelerated Blood Clearance Phenomenon Reduces the Passive Targeting of PEGylated Nanoparticles in Peripheral Arterial Disease
- (2016) Hyung-Jun Im et al. ACS Applied Materials & Interfaces
- PEGylation as a strategy for improving nanoparticle-based drug and gene delivery
- (2016) Jung Soo Suk et al. ADVANCED DRUG DELIVERY REVIEWS
- Paclitaxel-loaded PEGylated nanocapsules of perfluorooctyl bromide as theranostic agents
- (2016) Tanguy Boissenot et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Anti-PEG antibodies in the clinic: Current issues and beyond PEGylation
- (2016) Peng Zhang et al. JOURNAL OF CONTROLLED RELEASE
- An integrated assessment of morphology, size, and complement activation of the PEGylated liposomal doxorubicin products Doxil®, Caelyx®, DOXOrubicin, and SinaDoxosome
- (2016) Peter P. Wibroe et al. JOURNAL OF CONTROLLED RELEASE
- Factor H inhibits complement activation induced by liposomal and micellar drugs and the therapeutic antibody rituximab in vitro
- (2016) Tamás Mészáros et al. Nanomedicine-Nanotechnology Biology and Medicine
- Complement activation as a bioequivalence issue relevant to the development of generic liposomes and other nanoparticulate drugs
- (2015) Janos Szebeni et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Relationship between the Concentration of Anti-polyethylene Glycol (PEG) Immunoglobulin M (IgM) and the Intensity of the Accelerated Blood Clearance (ABC) Phenomenon against PEGylated Liposomes in Mice
- (2015) Yosuke Hashimoto et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- Anti-PEG IgM and complement system are required for the association of second doses of PEGylated liposomes with splenic marginal zone B cells
- (2015) Taro Shimizu et al. IMMUNOBIOLOGY
- Advanced therapeutic approach for the treatment of malignant pleural mesothelioma via the intrapleural administration of liposomal pemetrexed
- (2015) Hidenori Ando et al. JOURNAL OF CONTROLLED RELEASE
- Polyethylene glycol (PEG)-dendron phospholipids as innovative constructs for the preparation of super stealth liposomes for anticancer therapy
- (2015) Gianfranco Pasut et al. JOURNAL OF CONTROLLED RELEASE
- Anti-PEG immunity: emergence, characteristics, and unaddressed questions
- (2015) Qi Yang et al. Wiley Interdisciplinary Reviews-Nanomedicine and Nanobiotechnology
- Advances and Challenges of Liposome Assisted Drug Delivery
- (2015) Lisa Sercombe et al. Frontiers in Pharmacology
- Liposomal siRNA nanocarriers for cancer therapy
- (2014) Bulent Ozpolat et al. ADVANCED DRUG DELIVERY REVIEWS
- Hypersensitivity Reactions to Intravenous Lipid Emulsion in Swine
- (2014) Peter Bedocs et al. ANESTHESIA AND ANALGESIA
- Influence of phospholipid types and animal models on the accelerated blood clearance phenomenon of PEGylated liposomes upon repeated injection
- (2014) Huan Xu et al. DRUG DELIVERY
- Potential induction of anti-PEG antibodies and complement activation toward PEGylated therapeutics
- (2014) Johan J.F. Verhoef et al. DRUG DISCOVERY TODAY
- Influence of dose and animal species on accelerated blood clearance of PEGylated liposomal doxorubicin
- (2014) Takuya Suzuki et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Features of complement activation-related pseudoallergy to liposomes with different surface charge and PEGylation: Comparison of the porcine and rat responses
- (2014) László Dézsi et al. JOURNAL OF CONTROLLED RELEASE
- Complement activation-related pseudoallergy: A stress reaction in blood triggered by nanomedicines and biologicals
- (2014) Janos Szebeni MOLECULAR IMMUNOLOGY
- Immediate hypersensitivity reaction following liposomal amphotericin-B (AmBisome) infusion
- (2014) Proggananda Nath et al. TROPICAL DOCTOR
- Biomedical Nanoparticles: Overview of Their Surface Immune-Compatibility
- (2014) Olimpia Gamucci et al. Coatings
- Prolongation of time interval between doses could eliminate accelerated blood clearance phenomenon induced by pegylated liposomal topotecan
- (2013) ChunLei Li et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Use of polyglycerol (PG), instead of polyethylene glycol (PEG), prevents induction of the accelerated blood clearance phenomenon against long-circulating liposomes upon repeated administration
- (2013) Amr S. Abu Lila et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- The influence of lipid composition and surface charge on biodistribution of intact liposomes releasing from hydrogel-embedded vesicles
- (2013) A. Alinaghi et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- The accelerated blood clearance (ABC) phenomenon: Clinical challenge and approaches to manage
- (2013) Amr S. Abu Lila et al. JOURNAL OF CONTROLLED RELEASE
- Application of Polyglycerol Coating to Plasmid DNA Lipoplex for the Evasion of the Accelerated Blood Clearance Phenomenon in Nucleic Acid Delivery
- (2013) Amr S. Abu Lila et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- The safety and efficacy of peginesatide in patients with CKD
- (2013) Kai-Uwe Eckardt Nature Reviews Nephrology
- Peginesatide for Anemia in Patients with Chronic Kidney Disease Not Receiving Dialysis
- (2013) Iain C. Macdougall et al. NEW ENGLAND JOURNAL OF MEDICINE
- Liposomal drug delivery systems: From concept to clinical applications
- (2012) Theresa M. Allen et al. ADVANCED DRUG DELIVERY REVIEWS
- Role of the Methoxy Group in Immune Responses to mPEG-Protein Conjugates
- (2012) Merry R. Sherman et al. BIOCONJUGATE CHEMISTRY
- Peginesatide for Maintenance Treatment of Anemia in Hemodialysis and Nondialysis Patients Previously Treated with Darbepoetin Alfa
- (2012) S. Fishbane et al. Clinical Journal of the American Society of Nephrology
- Antibodies against polyethylene glycol in healthy subjects and in patients treated with PEG-conjugated agents
- (2012) Ricardo P Garay et al. Expert Opinion on Drug Delivery
- Transport of PEGylated liposomes from the splenic marginal zone to the follicle in the induction phase of the accelerated blood clearance phenomenon
- (2012) Taro Shimizu et al. IMMUNOBIOLOGY
- Multiple administration of PEG-coated liposomal oxaliplatin enhances its therapeutic efficacy: A possible mechanism and the potential for clinical application
- (2012) Amr S. Abu Lila et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Accelerated blood clearance of PEGylated liposomes containing doxorubicin upon repeated administration to dogs
- (2012) Takuya Suzuki et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Abrogation of the accelerated blood clearance phenomenon by SOXL regimen: Promise for clinical application
- (2012) Ai Nagao et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Prevention of infusion reactions to PEGylated liposomal doxorubicin via tachyphylaxis induction by placebo vesicles: A porcine model
- (2012) János Szebeni et al. JOURNAL OF CONTROLLED RELEASE
- Doxil® — The first FDA-approved nano-drug: Lessons learned
- (2012) Yechezkel (Chezy) Barenholz JOURNAL OF CONTROLLED RELEASE
- Accelerated Blood Clearance of Pegylated Liposomal Topotecan: Influence of Polyethylene Glycol Grafting Density and Animal Species
- (2012) Chunlei Li et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Activation of complement by therapeutic liposomes and other lipid excipient-based therapeutic products: Prediction and prevention
- (2011) Janos Szebeni et al. ADVANCED DRUG DELIVERY REVIEWS
- Factors affecting the pharmacokinetics of pegylated liposomal doxorubicin in patients
- (2011) Ninh M. La-Beck et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Repeated injections of PEGylated liposomal topotecan induces accelerated blood clearance phenomenon in rats
- (2011) Yanling Ma et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Liposome-induced complement activation and related cardiopulmonary distress in pigs: factors promoting reactogenicity of Doxil and AmBisome
- (2011) János Szebeni et al. Nanomedicine-Nanotechnology Biology and Medicine
- Evasion of the Accelerated Blood Clearance Phenomenon by Coating of Nanoparticles with Various Hydrophilic Polymers
- (2010) Tsutomu Ishihara et al. BIOMACROMOLECULES
- PEGylation of therapeutic proteins
- (2010) Simona JevsÌevar et al. Biotechnology Journal
- Complement: Alive and Kicking Nanomedicines
- (2010) Alina J. Andersen et al. Journal of Biomedical Nanotechnology
- Curvature of Synthetic and Natural Surfaces Is an Important Target Feature in Classical Pathway Complement Activation
- (2010) Martin Bjerregård Pedersen et al. JOURNAL OF IMMUNOLOGY
- Delivery of Therapeutic Proteins
- (2010) Dipak S. Pisal et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Repeated injection of pegylated liposomal antitumour drugs induces the disappearance of the rapid distribution phase
- (2010) JingXia Cui et al. JOURNAL OF PHARMACY AND PHARMACOLOGY
- Anti-PEG IgM Response against PEGylated Liposomes in Mice and Rats
- (2010) Masako Ichihara et al. Pharmaceutics
- Minireview: Nanoparticles and the Immune System
- (2009) Banu S. Zolnik et al. ENDOCRINOLOGY
- Oxaliplatin encapsulated in PEG-coated cationic liposomes induces significant tumor growth suppression via a dual-targeting approach in a murine solid tumor model
- (2009) Amr S. Abu Lila et al. JOURNAL OF CONTROLLED RELEASE
- The role of the anaphylatoxins in health and disease
- (2009) Andreas Klos et al. MOLECULAR IMMUNOLOGY
- Phase III Trial of Gemcitabine Compared With Pegylated Liposomal Doxorubicin in Progressive or Recurrent Ovarian Cancer
- (2008) Gabriella Ferrandina et al. JOURNAL OF CLINICAL ONCOLOGY
- Liposome-Mediated Triggering of Complement Cascade
- (2008) S. Moein Moghimi et al. JOURNAL OF LIPOSOME RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started